News / Business
Antares Pharma Inc (AMEX:AIS) to Hold Q4 2007 Earnings Conference Call March 26
Antares Pharma Inc (AMEX:AIS) will hold a conference call on Wednesday, March 26 at 8:00 am to discuss the fourth quarter earnings for 2007.
Specialized in pharma product development, Antares Pharma is a pipeline company offering drug delivery platforms, such as Advanced Transdermal Delivery (ATD) gels, fast melt oral (Easy Tec) tablets, disposable mini-needle injection systems (Vibex) and reusable needle-free injection systems (VISION and Valeo).
Anturol oxybutynin is the company’s lead ATD gell product and is used to treat overactive bladder. It is the anti-cholinergic oxybutynin is uses to sustain therapeutic blood levels for over 24 hours. The product was the only candidate in clinical studies as of March 27, 2007.
The company operates facilities in the
Antares Pharma Inc (AMEX:AIS)
For more Conference Call related events or to post your own events, visit:
